Evidence map›Paper›PMID 23972033›Full record

ArticleBiochemistry2013

Topology of the yeast Ras converting enzyme as inferred from cysteine accessibility studies.

Emily R Hildebrandt, Dillon M Davis, John Deaton, Ranjith K Krishnankutty, Edward Lilla, Walter K Schmidt

Abstract read
In one paragraph

Article in Biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Rce1: mechanism and inhibition.Critical reviews in biochemistry and molecular biology · 2018
    Review
  6. Article
  7. The higher level of complexity of K-Ras4B activation at the membrane.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2016
    Article
  8. Protein prenylation: unique fats make their mark on biology.Nature reviews. Molecular cell biology · 2016
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emily R HildebrandtDepartment of Biochemistry and Molecular Biology, The University of Georgia , Athens, Georgia 30602, United States.
Dillon M Davis
John Deaton
Ranjith K Krishnankutty
Edward Lilla
Walter K Schmidt

Funding

Role of Rce1p in the Biogenesis of CaaX ProteinsR01GM067092 · NIGMS · UNIVERSITY OF GEORGIA (UGA) · PI SCHMIDT, WALTER K · 2005 to 2009
$1.2M
NIGMS NIH HHS 5R01GM067092NIGMS NIH HHS R01 GM067092
6 · The paper itself

Abstract

The Ras converting enzyme (Rce1p) is an endoprotease that is involved in the post-translational processing of the Ras GTPases and other isoprenylated proteins. Its role in Ras biosynthesis marks Rce1p as an anticancer target. By assessing the chemical accessibility of cysteine residues substituted throughout the Saccharomyces cerevisiae Rce1p sequence, we have determined that yeast Rce1p has eight segments that are protected from chemical modification. Notably, the three residues that are essential for yeast Rce1p function (E156, H194, and H248) are all chemically inaccessible and associated with separate protected segments. By specifically assessing the chemical reactivity and glycosylation potential of the NH2 and COOH termini of Rce1p, we further demonstrate that Rce1p has an odd number of transmembrane spans. Substantial evidence that the most NH2-terminal segment functions as a transmembrane segment with the extreme NH2 terminus projecting into the endoplasmic reticulum (ER) lumen is presented. Because each of the remaining seven segments is too short to contain two spans and is flanked by chemically reactive positions, we infer that these segments are not transmembrane segments but rather represent compact structural features and/or hydrophobic loops that penetrate but do not fully span the bilayer (i.e., re-entrant helices). We thus propose a topological model in which yeast Rce1p contains a single transmembrane helix localized at its extreme NH2 terminus and one or more re-entrant helices and/or compact structural domains that populate the cytosolic face of the ER membrane. Lastly, we demonstrate that the natural cysteine residues of Rce1p are chemically inaccessible and fully dispensable for in vivo enzyme activity, formally eliminating the possibility of a cysteine-based enzymatic mechanism for this protease.

Indexed as

Amino Acid SequenceAnimalsCysteineEndoplasmic ReticulumHumansMaleimidesMetalloendopeptidasesPolyethylene GlycolsProprotein ConvertasesProtein PrenylationProtein Structure, SecondarySaccharomyces cerevisiae ProteinsSequence AlignmentSulfhydryl ReagentsCysteineMaleimidesMetalloendopeptidasesPolyethylene GlycolsProprotein ConvertasesRCE1 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSulfhydryl Reagents

Identifiers

PMID23972033
PMCPMC3831529

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.